Pulse Biosciences

$22.01 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Pulse Biosciences

Pulse Biosciences, Inc. is a clinical-stage medical device company using a platform technology called Nano-Pulse stimulating (NPS). NPS is a non-thermal, precise, focal drug-free electroceutical treatment technology that initiates cell death within treated tissue. NPS provides treatment in a range of immuno-oncology, dermatology and aesthetic applications. It offers treatment for minimally invasive applications, such as cardiac ablation, lung disease, Barret's esophagus, thyroid nodules, and ear, nose and throat (ENT) papillomas. The Company is developing PulseTx system (PulseTx), a system for the delivery of NPS treatments. The PulseTx system delivers NPS pulses through its tunable pulse generator and its planned suite of electrodes. The PulseTx system pulses are applied directly to tissue through electrodes, creating transient nanometer pores in cell and organelle membranes.

Stock Analysis

last close $22.01
1-mo return 6.7%
3-mo return 16.7%
avg daily vol. 31.18T
52-week high 45.82
52-week low 11.6
market cap. $641M
forward pe -
annual div. -
roe -118.7%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 11%
baraka

Subscribe now for daily local and international financial news

Subscribe